An update to “The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe” |
| |
| Authors: | Mark Jit |
| |
| Affiliation: | Modelling and Economics Unit, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, United Kingdom;1. Julius Centre for Health Sciences and Primary Care, University Medical Centre, Utretch, Netherlands;2. Centre for Prevention and Health Services Research, National Institute for Public Health and the Environment, Netherlands; Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, France; Centre for Health Economics Research and Modelling of Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Belgium; National Institute for Health and Welfare (THL), Finland;1. Centre for Infections, Health Protection Agency, United Kingdom;2. London School of Hygiene and Tropical Medicine, United Kingdom; Centre for Health Economics Research and Modelling of Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Belgium |
| |
| Abstract: | A cost-effectiveness analysis of rotavirus vaccination in Belgium, England and Wales, Finland, France and the Netherlands published in 2009 was updated based on recent studies on rotavirus burden of disease and vaccine efficacy. All the qualitative conclusions in the previous study were found to remain valid. Vaccination remains cost-effective in Finland only when using plausible tender prices. |
| |
| Keywords: | Rotavirus Vaccination Cost-effectiveness |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
